Cochrane Abstracts
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis New Search for Studies and Content Updated (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Photorefractive_keratectomy__PRK__versus_laser_assisted_in_situ_keratomileusis__LASIK__for_hyperopia_correction_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 30 May 2023.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Photorefractive_keratectomy__PRK__versus_laser_assisted_in_situ_keratomileusis__LASIK__for_hyperopia_correction_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed May 30, 2023.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Photorefractive_keratectomy__PRK__versus_laser_assisted_in_situ_keratomileusis__LASIK__for_hyperopia_correction_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis New Search for Studies and Content Updated (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 May 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Photorefractive_keratectomy__PRK__versus_laser_assisted_in_situ_keratomileusis__LASIK__for_hyperopia_correction_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions)
ID - 431470
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Photorefractive_keratectomy__PRK__versus_laser_assisted_in_situ_keratomileusis__LASIK__for_hyperopia_correction_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
